Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in adolescents with Bipolar I Disorder
NCT00035802Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in bipolar I disorder, sponsored by Johnson & Johnson. Started Jan 2002; status: completed.
02
Drugs
topiramate
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00035802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035802.